Literature DB >> 1509980

Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice.

M Perretti1, E Solito, L Parente.   

Abstract

As a putative mediator of inflammation interleukin-1 has been implicated in the recruitment of leukocytes during the early stages of the inflammatory reaction. In the present report we have investigated the release of endogenous IL-1 in the rat zymosan pleurisy and in the mouse zymosan peritonitis. In both cases the release of the cytokine was maximal 4 hours after zymosan injection and appeared to be time-related to neutrophil migration into the inflammatory site. The effect of in vivo treatment with dexamethasone in rat pleurisy and with polyclonal anti-murine IL-1 beta antibody in mouse peritonitis was also assessed. The steroid reduced both cell migration and the release of IL-1-like activity as well as the formation of exudate and the release of eicosanoids. The anti-IL-1 beta serum inhibited selectively the number of neutrophil that migrated to the inflamed site (approximately 40%) and the IL-1 activity recovered in (approximately 70%) the exudate. In vitro incubation of the inflammatory exudate with polyclonal anti-murine IL-1 alpha or anti-murine IL-1 beta sera allowed the identification of the IL-1 species present. In the rat pleurisy IL-1 biological activity was mainly due to the alpha species, whereas IL-1 beta was the only species apparently present in the mouse peritoneal exudate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1509980     DOI: 10.1007/bf01990954

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  36 in total

1.  Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha.

Authors:  M B Furie; D D McHugh
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

Review 2.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Simple, sensitive and specific bioassay of interleukin-1.

Authors:  S J Hopkins; M Humphreys
Journal:  J Immunol Methods       Date:  1989-06-21       Impact factor: 2.303

Review 4.  Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.

Authors:  H Z Movat
Journal:  J Lab Clin Med       Date:  1987-12

5.  Studies on cell motility in inflammation. I. The chemotactic activity of experimental, immunological and non-immunological, inflammatory exudates.

Authors:  L Parente; M S Koh; D A Willoughby; A Kitchen
Journal:  Agents Actions       Date:  1979-06

6.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

7.  Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin- and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor.

Authors:  T J Sayers; T A Wiltrout; C A Bull; A C Denn; A M Pilaro; B Lokesh
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

8.  The effect of adrenalectomy on interleukin-1 release in vitro and in vivo.

Authors:  M Perretti; C Becherucci; G Scapigliati; L Parente
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

9.  Leukotrienes do not regulate interleukin 1 production by activated macrophages.

Authors:  B A Parkar; M E McCormick; S J Foster
Journal:  Biochem Biophys Res Commun       Date:  1990-06-15       Impact factor: 3.575

10.  The release of leukotriene B4 during experimental inflammation.

Authors:  P M Simmons; J A Salmon; S Moncada
Journal:  Biochem Pharmacol       Date:  1983-04-15       Impact factor: 5.858

View more
  25 in total

1.  Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.

Authors:  F A van de Loo; S Kuiper; F H van Enckevort; O J Arntz; W B van den Berg
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

2.  Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1.

Authors:  M Perretti; A Ahluwalia; J G Harris; H J Harris; S K Wheller; R J Flower
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation.

Authors:  M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells.

Authors:  S H P Oliveira; C Canetti; R A Ribeiro; F Q Cunha
Journal:  Inflammation       Date:  2008-02       Impact factor: 4.092

5.  Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenan-induced pleurisy in the rat.

Authors:  K P Meyers; C L Czachowski; J W Coffey
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

6.  A new assay for antiphlogistic activity: zymosan-induced mouse ear inflammation.

Authors:  F Erdö; K Török; P Arányi; J I Székely
Journal:  Agents Actions       Date:  1993-07

Review 7.  Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies.

Authors:  R Milanino; M Marrella; R Gasperini; M Pasqualicchio; G Velo
Journal:  Agents Actions       Date:  1993-07

8.  Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors.

Authors:  M Perretti; A Ahluwalia; R J Flower; S Manzini
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

9.  Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.

Authors:  C Zuany-Amorim; D Leduc; B B Vargaftig; M Pretolani
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin-induced diabetic mice.

Authors:  Y Kannan; M Tokunaga; M Moriyama; H Kinoshita; Y Nakamura
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.